Replies to post #456508 on NorthWest Biotherapeutics Inc (NWBO)

[meirluc]

If NWBO is in the combo trial, would they charge whoever is doing the trail with the vaccines they supply to them? How many total patients need vaccine? That is not small revenue I hope

I may be wrong but I have never heard that the vaccines prepared from the tumors of the patients enrolled in the combo trials are supplied by NWBO.
UCLA may have to pay a license fee that covers NWBO's methods of vaccine production that are utilized at UCLA but I doubt that this licensing fee (if it exists) would be very expensive because NWBO is definitely deriving validation benefits from the combo trials.

After all, the fact that every patient in the UCLA combo trials is treated with DCVax-L, tells us a lot about UCLA's faith in the vaccine's efficacy.

[exwannabe]

If NWBO is in the combo trial, would they charge whoever is doing the trail with the vaccines they supply to them? How many total patients need vaccine? That is not small revenue I hope.

We know as a fact that the vaccine in the combo trial is produced at UCLA.

We also know NWBO revenue numbers. They have always been small despite Specials and the HE that have been hyped for a decade.